Abstract
In total, 11 consecutive pediatric patients with Griscelli syndrome (GS) type 2, who received allogeneic hematopoietic SCT (aHSCT) at our center between 1993 and 2007, were reviewed. The median age at transplantation was 8.2 months (range, 4–36.3 months) and the median time from diagnosis to transplantation was 3.7 months (range, 1.4–19.5 months). Seven patients developed an accelerated phase and were treated with chemotherapy before transplantation. At the time of transplantation, all patients were in clinical remission. The source of grafts was matched-related marrows in eight patients and partially mismatched unrelated cords in three patients. All patients were engrafted at a median time of 15 days (range, 12–36 days). Grade I–II acute GVHD and veno-occlusive disease occurred in three and one patient, respectively. A total of 10 patients are now alive and disease free at a median of 4.8 years post-HSCT. The post transplant course was complicated by CMV infection in four patients. One patient died in remission from septic shock, 6 months after transplantation. Chimerism studies at the last contact are available for nine patients: six patients have complete donor chimerism and three have stable mixed chimerism. Early aHSCT from matched-related donors or unrelated cord blood for children with GS is feasible.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Griscelli C, Durandy A, Guy-Grand D, Daguillard F, Herzog C, Prunieras M . A syndrome associating partial albinism and immunodeficiency. Am J Med 1978; 65: 691–702.
Siccardi AG, Bianchi E, Calligari A, Clivio A, Fortunato A, Magrini U et al. A new familial defect in neutrophil bactericidal activity. Helv Paediatr Acta 1978; 33: 401–412.
Pastural E, Barrat FJ, Dufoureq-Lagelouse R, Certain S, Sanal O, Jabade N et al. Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin Va gene. Nat Genet 1997; 16: 289–292.
Sanal O, Yel L, Kucukali T, Gilbert-Barnes E, Tardieu M, Tezcan I et al. An allelic variant of Griscelli disease: presentation with severe hypotonia mental-motor retardation, and hypopigmentation consistent with Elejalde syndrome (neuroectodermal melanolysosomal disorder). J Neurol 2000; 247: 570–572.
Menasche G, Ho CH, Sanal O, Feldmann J, Tezcan I, Ersoy F et al. Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1). J Clin Invest 2003; 112: 450–456.
Klein C, Philippe N, Le Deist F, Fraitag S, Prost C, Durandy A et al. Partial albinism with Immunodeficiency (Griscelli syndrome). J Pediatr 1994; 125: 886–895.
Menasche G, Pastural E, Feldmann J, Certain S, Ersoy F, Dupuis S et al. Mutations in RAB27A cause Griscelli syndrome associated with hemophagocytic syndrome. Nat Genet 2000; 25: 173–176.
Kumar M, Sackey K, Schmalstieg F, Trizna Z, Elghetany MT, Alter BP . Griscelli syndrome: a rare neonatal syndrome of recurrent hemophagocytosis. J Pediatr Hematol Oncol 2001; 23: 464–468.
Schneider L, Berman R, Shea C, Perez-Atayde A, Weinstein H, Geha R . Bone marrow transplantation (BMT) for the syndrome of pigmentary dilution and lymphohistiocytosis (Griscelli's syndrome). J Clin Immunol 1990; 10: 146–153.
Baumeister F, Stachel D, Schuster F, Schmid I, Schaller M, Wolff H et al. Accelerated phase in partial albinism with immunodeficency (Griscelli syndrome): genetics and stem cell transplantation in a 2-month-old girl. Eur J Pediatr 2000; 159: 74–78.
Fischer A, Griscelli C, Friedrich W, Kubanek B, Levinsky R, Morgan G et al. Bone-marrow transplantation for immuno-deficiencies and osteopetrosis: European Survey 1968–1985. Lancet 1986; 2: 1080–1084.
Aricò M, Zecca M, Santoro N, Caselli D, Maccario R, Danesino C et al. Successful treatment of Griscelli syndrome with unrelated donor allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 995–998.
Tezcan I, Sanal O, Ersoy F, Uckan D, Kiliç S, Metin A et al. Successful bone marrow transplantation in a case of Griscelli disease which presented in accelerated phase with neurological involvement. Bone Marrow Transplant 1999; 24: 931–933.
Schuster F, Stachel DK, Schmid I, Baumeister FA, Graubner UB, Weiss M et al. Griscelli syndrome: report of the first peripheral blood stem cell transplant and the role of mutations in the RAB27A gene as an indication for BMT. Bone Marrow Transplant 2001; 28: 409–412.
Henter JI, Elinder G, Ost A . Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991; 18: 29–33.
Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124–131.
Haddad E, Sulis ML, Jabado N, Blanche S, Fischer A, Tardieu M . Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood 1997; 89: 794–800.
Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of GVHD in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295–299.
Atkinson K, Horowitz MM, Gale RP, Lee MB, Rimm AA, Bortin MM . Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Bone Marrow Transplant 1989; 4: 247–254.
Henter JI, Samuelsson-Horne A, Arico M, Egeler RM, Elinder G, Filipovich AH et al. Treatment of Hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002; 100: 2367–2373.
Horne A, Janka G, Egeler RM, Gadner H, Imashuku S, Ladisch S et al. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Br J Haematol 2005; 129: 622–630.
Baker KS, DeLaat CA, Steinbuch M, Gross TG, Shapiro RS, Loechelt B et al. Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow. Blood 1997; 89: 3857–3863.
Haddad BE, Le Deist F, Blanche S, Benkerrou M, Rohrlich P, Vilmer E et al. Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: report of 10 cases. Blood 1995; 85: 3328–3333.
Henter JI, Samuelsson-Horne AC, Maurizio A, Egeler RM, Elinder G, Filipovich AH et al. Treatment of Hemophagocytic lymphohistiocytosis with HLH-94 immuno-chemotherapy and bone marrow transplantation. Blood 2002; 100: 2367–2373.
Ouachee-Chardin M, Elie C, de Saint Basile G, Le Deist F, Mahlaoui N, Picard C et al. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis. A single-center report of 48 patients. Pediatrics 2006; 117: e743–e750. DOI: 10.1542/peds.2005-1789.
Pachlopnik Schmid J, Moshous DM, Cavazzana-Calvo M, Blanche S, de Saint Basile G, Fischer A . Haematopoietic stem cell transplantation in Griscelli Syndrome type 2: a single center report of 10 patients. Bone Marrow Transplant 2009; 43 (Suppl 1): S182 (abstract 686).
Chalandon Y, Roosnek E, Mermillod B, Newton A, Ozsahin H, Wacker P . Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2004; 10: 347–354.
Landman-Parker J, Le Deist F, Blaise A, Brison O, Fischer A . Partial engraftment of donor bone marrow cells associated with long-term remission of haemophagocytic lymphohistiocytosis. Br J Haematol 1993; 85: 37–41.
Acknowledgements
We thank the families of the patients, nursing and medical staff of the BMT unit.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Al-Ahmari, A., Al-Ghonaium, A., Al-Mansoori, M. et al. Hematopoietic SCT in children with Griscelli syndrome: a single-center experience. Bone Marrow Transplant 45, 1294–1299 (2010). https://doi.org/10.1038/bmt.2009.358
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2009.358
Keywords
This article is cited by
-
Development, characterization, and hematopoietic differentiation of Griscelli syndrome type 2 induced pluripotent stem cells
Stem Cell Research & Therapy (2021)
-
Neuro-Regression in a Child with Silvery Hair
Indian Journal of Pediatrics (2021)
-
Hematopoietic stem cell transplantation in children with Griscelli syndrome type 2: a single-center report on 35 patients
Bone Marrow Transplantation (2020)
-
Atypical Chédiak-Higashi syndrome with attenuated phenotype: three adult siblings homozygous for a novel LYST deletion and with neurodegenerative disease
Orphanet Journal of Rare Diseases (2013)